MedPath
FDA Approval

Granisetron Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 4, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Granisetron(1 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

HIKMA FARMACEUTICA (PORTUGAL), S.A

Hikma Pharmaceuticals USA Inc.

452742943

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Granisetron Hydrochloride

Product Details

NDC Product Code
0143-9744
Application Number
ANDA078629
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
January 4, 2024
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 9 mg in 1 mL
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACTQuantity: 2 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: 318F6L70J8Class: ACTIMQuantity: 1 mg in 1 mL
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACTQuantity: 10 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT

Granisetron Hydrochloride

Product Details

NDC Product Code
0143-9745
Application Number
ANDA078629
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
January 4, 2024
Code: 318F6L70J8Class: ACTIMQuantity: 1 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACTQuantity: 10 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 9 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACTQuantity: 2 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath